Long-Term Treatment with Slow-Release Frusemide Compared with Thiazide Treatment in Arterial Hypertension

Abstract

The effect of 30 mg/day slow-release frusemide given orally for 12 months was studied in 64 patients previously treated with thiazides for mild to moderate essential hypertension. Frusemide had a significant antihypertensive effect (P<0.001), and compared to thiazides significantly reduced fasting serum glucose (P<0.015), haemoglobin A_1c (P<0.025), albumin (P<0.025) and serum calcium (P<0.025), and significantly increased serum sodium and chloride concentrations (P<0.0001). There was also a non-significant trend for frusemide to reduce serum total cholesterol, triglycerides and urate, and to increase serum potassium. Frusemide was well tolerated in all but three patients. It is concluded that slow-release frusemide has a comparable antihypertensive effect to that of thiazide diuretics, but has fewer metabolic side-effects, and should be used in preference to thiazides for the treatment of arterial hypertension when a diuretic is indicated.

Keywords

Slow-release frusemide thiazide arterial hypertension metabolic side-effects

Get full access to this article

View all access options for this article.

References

Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects on treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143–1152.

Helgeland

: Treatment of mild hypertension: a five year controlled drug trial. The Oslo Study. Am J Med 1980; 69: 725–732.

Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97–104.

Leren

: Effects of antihypertensive drugs on lipid metabolism. Clin Ther 1987; 9: 326–332.

Ames

Hill

: Increase in serum lipids during treatment of hypertension with chlorthalidone. Lancet 1976; i: 721–723.

Morgan

Davidson

: Hypokalemia and diuretics; an analysis of publications. Br Med J 1980; 280: 905–980.

Murphy

Lewis

Kohner

: Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet 1982; ii: 1293–1295.

Houston

: Adverse effect of antihypertensive drug therapy on glucose intolerance. Cardiol Clin 1986; 4: 117–135.

Lardionis

Neuman

: The effects of antihypertensive agents on serum lipids and lipoproteins. Arch Intern Med 1988; 148: 1280–1288.

10.

Leary

Asmal

: Slow-release furosemide in the treatment of mild to moderate hypertension. Curr Ther Res 1980; 28: 549–553.

11.

Berglund

Samuelsson

: Lowered blood pressure and the J-shaped curve. Lancet 1987; i: 1154–1155.

12.

Bloomgarden

Ginsberg-Fellner

Rayfield

: Elevated hemoglobin A_1c and low-density lipoprotein cholesterol levels in fhiazide-treated diabetic patients. Am J Med 1984; 77: 823–827.

13.

Hylander

Danielson

Fliasson

: Comparison of hydrochlorothiazide and slow-release furosemide as adjuvant therapy to β-blockers in the treatment of moderate hypertension. Acta Med Scand 1987; 222: 137–142.

14.

Editorial: Dietary potassium and hypertension. Lancet 1985; i: 1308–1309.

15.

Fuller

Shipley

Rose

: Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980; i: 1373–1376.

16.

Oswald

Corcoran

Yudkin

: Prevalance and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984; i: 1264–1267.

17.

Berglund

Andersson

Widgren

: Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide. Acta Med Scand 1986; 220: 419–424.

18.

Licht

Haley

Pugh

: Diuretic regimens in essential hypertension. A comparison of hypokalemic effects, blood pressure control and cost. Arch Intern Med 1984; 143: 1694–1699.

19.

Kohvakka

Salo

Gordin

: Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene. Acta Med Scand 1988; 219: 381–386.